These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 3529311)

  • 1. Haemophilus influenzae type b infections in day care attendees: implications for management.
    Daum RS; Granoff DM; Gilsdorf J; Murphy T; Osterholm MT
    Rev Infect Dis; 1986; 8(4):558-67. PubMed ID: 3529311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Haemophilus influenzae type b infections in day care: a public health perspective.
    Fleming DW; Cochi SL; Hull HF; Helgerson SD; Cundiff DR; Broome CV
    Rev Infect Dis; 1986; 8(4):568-72. PubMed ID: 3529312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-benefit analysis of two strategies for prevention of Haemophilus influenzae type b infection.
    Hay JW; Daum RS
    Pediatrics; 1987 Sep; 80(3):319-29. PubMed ID: 3114708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemophilus influenzae disease and immunization in developing countries.
    Funkhouser A; Steinhoff MC; Ward J
    Rev Infect Dis; 1991; 13 Suppl 6():S542-54. PubMed ID: 1862284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outbreak of Haemophilus influenzae type b meningitis in a day care center.
    Andersson von Rosen I; Gotherfors L; Schmeisser S; Tärnvik A; Svanborg Edén C
    Pediatr Infect Dis J; 1990 May; 9(5):326-32. PubMed ID: 2352817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease.
    Singleton R; Hammitt L; Hennessy T; Bulkow L; DeByle C; Parkinson A; Cottle TE; Peters H; Butler JC
    Pediatrics; 2006 Aug; 118(2):e421-9. PubMed ID: 16882783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of Haemophilus influenzae type B: failure of rifampin prophylaxis in a day care center.
    Wilde J; Adler SP
    Pediatr Infect Dis; 1986; 5(5):505-8. PubMed ID: 3489926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and prospects for prevention of disease due to Haemophilus influenzae in developing countries.
    Munson RS; Kabeer MH; Lenoir AA; Granoff DM
    Rev Infect Dis; 1989; 11 Suppl 3():S588-97. PubMed ID: 2669102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemophilus influenzae type b disease in an Amish population: studies of the effects of genetic factors, immunization, and rifampin prophylaxis on the course of an outbreak.
    Granoff DM; McKinney T; Boies EG; Steele NP; Oldfather J; Pandey JP; Suarez BK
    Pediatrics; 1986 Mar; 77(3):289-95. PubMed ID: 3485275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of rifampin in eliminating pharyngeal carriage of Haemophilus influenzae type b.
    Shapiro ED; Wald ER
    Pediatrics; 1980 Jul; 66(1):5-8. PubMed ID: 6967587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary Haemophilus influenzae type b in day-care facilities. Risk factors and prevention.
    Fleming DW; Leibenhaut MH; Albanes D; Cochi SL; Hightower AW; Makintubee S; Helgerson SD; Broome CV
    JAMA; 1985 Jul; 254(4):509-14. PubMed ID: 3874293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment.
    Cochi SL; Broome CV; Hightower AW
    JAMA; 1985 Jan; 253(4):521-9. PubMed ID: 3918181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Haemophilus vaccines. Their importance in tropical pediatrics].
    Bégué P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):912-6. PubMed ID: 1819437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Apr; 34(15):201-5. PubMed ID: 3920487
    [No Abstract]   [Full Text] [Related]  

  • 15. World-wide strategies for immunization against invasive Haemophilus influenzae type b disease.
    Iwarson S
    Vaccine; 1993; 11 Suppl 1():S28-9. PubMed ID: 8447169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update: prevention of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(11):170-4, 179-80. PubMed ID: 3081787
    [No Abstract]   [Full Text] [Related]  

  • 17. Leads from the MMWR. Update: prevention of Haemophilus influenzae type b disease.
    JAMA; 1986 Apr; 255(15):1990-2. PubMed ID: 3485727
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiology of Haemophilus influenzae type b infections among children in Denmark in 1985 and 1986.
    Kristensen K; Kaaber K; Rønne T; Larsen SO; Henrichsen J
    Acta Paediatr Scand; 1990; 79(6-7):587-92. PubMed ID: 2386050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of subsequent disease among day-care contacts of patients with systemic Hemophilus influenzae type B disease.
    Murphy TV; Clements JF; Breedlove JA; Hansen EJ; Seibert GB
    N Engl J Med; 1987 Jan; 316(1):5-10. PubMed ID: 3491319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Need for prevention of invasive Haemophilus influenzae type b infections in Geneva, Switzerland.
    Gervaix A; Suter S
    Vaccine; 1993; 11 Suppl 1():S34-7. PubMed ID: 8447172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.